NeoPharm, Inc.
1850 Lakeside Dr Waukegan, IL 60085
Phone: (847) 887-0800
Web Site: www.neophrm.com
Industry: Drugs Sector: Healthcare
Employees: 98
Stock Symbol: NEOL

Business Summary NeoPharm, Inc. is a Delaware corporation incorporated on June 15, 1990 under the name of OncoMed, Inc. In March 1995, the Company changed its name to NeoPharm, Inc. During 2004, the Company established a wholly-owned subsidiary, NeoPharm EU Limited, in order to comply with regulatory requirements enacted by the European Union for clinical trials conducted in member countries. The Company is a biopharmaceutical company engaged in the research, development, and commercialization of drugs for the treatment of cancer. It has built its drug portfolio based on two proprietary technology platforms: the NeoLipid liposomal drug delivery system and a tumor-targeting toxin platform. The Company has four drug product candidates in various stages of clinical development for the treatment of cancer. The Company's most advanced drug product candidate is cintredekin besudotox, a tumor-targeting toxin being developed as a treatment for glioblastoma multiforme, a deadly form of brain cancer.